|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Interest earned on marketable securities held in Trust Account | |||||
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Provision to write down inventories to net realizable value | |||||
| Change in fair value of contingent shares liability | |||||
| Change in fair value of derivative liability | |||||
| Deferred tax benefit | |||||
| Non-cash interest expense | |||||
| Stock-based compensation | |||||
| Change in allowance for credit losses | |||||
| Loss on debt extinguishment | |||||
| Non-cash lease expense | |||||
| Accretion of interest on marketable securities | |||||
| Loss on disposal of property and equipment | |||||
| Gain on sale of intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Warranty liability | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of marketable securities | |||||
| Acquisition of fSight | |||||
| Purchase of intangible assets | |||||
| Purchase of property and equipment | |||||
| Sales and maturities of marketable securities | |||||
| Proceeds from sale of intangible assets | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Convertible Promissory Note | |||||
| Repayment of Series 2022-1 Notes | |||||
| Payment of financing costs | |||||
| Proceeds from Business Combination | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from at-the-market offering | |||||
| Proceeds from common stock warrant redemption, net of issuance costs and payments to warrant holders of non-redeemed warrants | |||||
| Payment of offering costs related to at-the-market offering | |||||
| Payment of tax withholdings on restricted stock awards | |||||
| Repayment of Convertible Note | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash paid for income taxes, net | |||||
| Italy | |||||
| Israel | |||||
| Total cash paid for income taxes, net | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| Net assets acquired from Roth CH Acquisition IV Co. | |||||
| Operating lease right of use assets obtained in exchange for operating lease liabilities | |||||
| Property and equipment in accounts payable | |||||
| Non-cash consideration paid for fSight acquisition | |||||
| Contingent shares liability from fSight acquisition | |||||
| Unrealized gain resulting from change in fair value of marketable securities | |||||
| Fair value of derivative note liability at issuance | |||||
| Convertible preferred stock dividends (Note 3) | |||||
| Reclassification of deferred issuance costs to additional paid in capital | |||||
| Conversion of convertible preferred stock into common stock in connection with the Business Combination (Note 3) | |||||
| Issuance of preferred stock upon exercise of preferred warrants | |||||
| Reclassification of convertible note derivative liability to equity | |||||
Loading...